Corporate Communications
Latest News
Advertisement
Latest Videos
Shorts
Advertisement
More News
Strategic alignment combines data-driven intelligence with pharma and biotech commercialization to support an integrated platform for healthcare and life sciences brands.
“This is about building a powerful bridge between the science that transforms lives and the systems that deliver that transformation,” said Michael J. Hennessy Jr., MJH Life Sciences chairman and CEO, of the BPD Healthcare acquisition.
A monthly roundup of business and people news in the pharmaceutical industry.
Legos will take over from Roger Dansey, who will begin transitioning to retirement.
Advertisement
Advertisement
Trending on PharmExec
1
What is it Like to Go From Treating Patients Directly to Running a Company?
2
FDA Grants Accelerated Approval to INOVIO’s Voceryq for RRP, Reducing Surgical Burden
3
States Take Center Stage in the Drug Pricing Fight
4
FDA Approves Ilumya for Adults With Active Psoriatic Arthritis
5